arrow
返回
D

Daniel F. Veber

机构信息待补充

52H指数
248论文数
1.8W被引数
收录论文 28
发表时间
Optimization of the Potency and Pharmacokinetic Properties of a Macrocyclic Ghrelin Receptor Agonist (Part I): Development of Ulimorelin (TZP-101) from Hit to Clinic
err2011-11-22
err69
PREAI
errHoveyda, Hamid R.; Marsault, Eric; Gagnon, Rene; Mathieu, Axel P.; Vezina, Martin; Landry, Annick; Wang, Zhigang; Benakli, Kamel; Beaubien, Sylvie; Saint-Louis, Carl; Brassard, Martin; Pinault, Jean-Francois; Ouellet, Luc; Bhat, Shridhar; Ramaseshan, Mahesh; Peng, Xiaowen; Foucher, Laurence; Beauchemin, Sophie; Bherer, Patrick; Veber, Daniel F.; Peterson, Mark L.; Fraser, Graeme L.
err分享
err收藏
Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo
err2009-12-04
err180
PREAI
errVotta, BJ; Levy, MA; Badger, A; Bradbeer, J; Dodds, RA; James, IE; Thompson, S; Bossard, MJ; Carr, T; Connor, JR; Tomaszek, TA; Szewczuk, L; Drake, FH; Veber, DF; Gowen, M
err分享
err收藏
Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption
err2009-12-02
err88
PREAI
errDodds, RA; James, IE; Rieman, D; Ahern, R; Hwang, SM; Connor, JR; Thompson, SD; Veber, DF; Drake, FH; Holmes, S; Lark, MW; Gowen, M
err分享
err收藏
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate人组织蛋白酶K的有效和选择性抑制导致非人灵长类动物体内骨吸收的抑制
err2009-12-02
err161
PREAI
errStroup, GB; Lark, MW; Veber, DF; Bhattacharyya, A; Blake, S; Dare, LC; Erhard, KF; Hoffman, SJ; James, IE; Marquis, RW; Ru, Y; Vasko-Moser, JA; Smith, BR; Tomaszek, T; Gowen, M
err分享
err收藏
Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore
err2007-07-18
err90
PREAI
errMarino, Joseph P., Jr.; Fisher, Paul W.; Hofmann, Glenn A.; Kirkpatrick, Robert B.; Janson, Cheryl A.; Johnson, Randall K.; Ma, Chun; Mattern, Michael; Meek, Thomas D.; Ryan, M. Dominic; Schulz, Christina; Smith, Ward W.; Tew, David G.; Tomazek, Thaddeus A., Jr.; Veber, Daniel F.; Xiong, Wenfang C.; Yamamoto, Yuuichi; Yamashita, Keizo; Yang, Guang; Thompson, Scott K.
err分享
err收藏
A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys组织蛋白酶K的高效抑制剂 (relacatib) 在体外和猴子体内骨转换升高的急性模型中均降低了骨吸收的生物标志物
errBONE
IF3.6
err2007-01-01
err120
PREAI
errKumar, S.; Dare, L.; Vasko-Moser, J. A.; James, I. E.; Blake, S. M.; Rickard, D. J.; Hwang, S. -M.; Tomaszek, T.; Yamashita, D. S.; Marquis, R. W.; Oh, H.; Jeong, J. U.; Veber, D. F.; Gowen, M.; Lark, M. W.; Stroup, G.
err分享
err收藏
Structure activity relationships of 5-, 6-, and 7-methyl -substituted azepan-3-one cathepsin K inhibitors
err2006-02-15
err61
PREAI
errYamashita, DS; Marquis, RW; Xie, R; Nidamarthy, SD; Oh, HJ; Jeong, JU; Erhard, KF; Ward, KW; Roethke, TJ; Smith, BR; Cheng, HY; Geng, XL; Lin, F; Offen, PH; Wang, B; Nevins, N; Head, MS; Haltiwanger, RC; Sarjeant, AAN; Liable-Sands, LM; Zhao, BG; Smith, WW; Janson, CA; Gao, E; Tomaszek, T; McQueney, M; Jarnes, IE; Gress, CJ; Zembryki, DL; Lark, MW; Veber, DF
err分享
err收藏
Azepanone-based inhibitors of human cathepsin L
err2005-09-30
err31
PREAI
errMarquis, RW; James, I; Zeng, J; Trout, REL; Thompson, S; Rahman, A; Yamashita, DS; Xie, R; Ru, Y; Gress, CJ; Blake, S; Lark, MA; Hwang, SM; Tomaszek, T; Offen, P; Head, MS; Cummings, MD; Veber, DF
err分享
err收藏
4-Aryl-1,2,3-triazole: A novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo
err2005-08-06
err209
PREAI
errKallander, LS; Lu, Q; Chen, WF; Tomaszek, T; Yang, G; Tew, D; Meek, TD; Hofmann, GA; Schulz-Pritchard, CK; Smith, WW; Janson, CA; Ryan, MD; Zhang, GF; Johanson, KO; Kirkpatrick, RB; Ho, TF; Fisher, PW; Mattern, MR; Johnson, RK; Hansbury, MJ; Winkler, JD; Ward, KW; Veber, DF; Thompson, SK
err分享
err收藏
Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor
err2004-02-11
err78
PREAI
errWiddowson, KL; Elliott, JD; Veber, DF; Nie, H; Rutledge, MC; McCleland, BW; Xiang, JN; Jurewicz, AJ; Hertzberg, RP; Foley, JJ; Griswold, DE; Martin, L; Lee, JM; White, JR; Sarau, HM
err分享
err收藏
Molecular properties that influence the oral bioavailability of drug candidates
err2002-05-11
err6.1K
PREAI
errVeber, DF; Johnson, SR; Cheng, HY; Smith, BR; Ward, KW; Kopple, KD
err分享
err收藏
2ND-GENERATION BENZODIAZEPINE CCK-B ANTAGONISTS - DEVELOPMENT OF SUBNANOMOLAR ANALOGS WITH SELECTIVITY AND WATER SOLUBILITY
err2002-05-01
err42
PREAI
errBOCK, MG; DIPARDO, RM; MELLIN, EC; NEWTON, RC; VEBER, DF; FREEDMAN, SB; SMITH, AJ; PATEL, S; KEMP, JA; MARSHALL, GR; FLETCHER, AE; CHAPMAN, KL; ANDERSON, PS; FREIDINGER, RM
err分享
err收藏
ORALLY ACTIVE, NONPEPTIDE OXYTOCIN ANTAGONISTS
err2002-05-01
err129
PREAI
errEVANS, BE; LEIGHTON, JL; RITTLE, KE; GILBERT, KF; LUNDELL, GF; GOULD, NP; HOBBS, DW; DIPARDO, RM; VEBER, DF; PETTIBONE, DJ; CLINESCHMIDT, BV; ANDERSON, PS; FREIDINGER, RM
err分享
err收藏
A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat
errBONE
IF3.6
err2002-05-01
err73
PREAI
errLark, MW; Stroup, GB; James, IE; Dodds, RA; Hwang, SN; Blake, SM; Lechowska, BA; Hoffman, SJ; Smith, BR; Kapadia, R; Liang, X; Erhard, K; Ru, Y; Dong, X; Marquis, RW; Veber, D; Gowen, M
err分享
err收藏
CYCLIC-PEPTIDES AS SELECTIVE TACHYKININ ANTAGONISTS
err2002-05-01
err41
PREAI
errWILLIAMS, BJ; CURTIS, NR; MCKNIGHT, AT; MAGUIRE, JJ; YOUNG, SC; VEBER, DF; BAKER, R
err分享
err收藏
DEVELOPMENT OF A POTENT THROMBIN RECEPTOR-LIGAND
err2002-05-01
err75
PREAI
errFENG, DM; VEBER, DF; CONNOLLY, TM; CONDRA, C; TANG, MJ; NUTT, RF
err分享
err收藏
Aspartic protease inhibitors: Expedient synthesis of 2-substituted statines
err2001-08-03
err15
PREAI
errTravins, JM; Bursavich, MG; Veber, DF; Rich, DH
err分享
err收藏
Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitro
err2001-04-01
err40
errOAAI
errJames, IE; Marquis, RW; Blake, SM; Hwang, SM; Gress, CJ; Ru, Y; Zembryki, D; Yamashita, DS; McQueney, MS; Tomaszek, TA; Oh, HJ; Gowen, M; Veber, DF; Lark, MW
err分享
err收藏
Azepanone-based inhibitors of human and rat cathepsin K
err2001-03-24
err126
PREAI
errMarquis, RW; Ru, Y; LoCastro, SM; Zeng, J; Yamashita, DS; Oh, HJ; Erhard, KF; Davis, LD; Tomaszek, TA; Tew, D; Salyers, K; Proksch, J; Ward, K; Smith, B; Levy, M; Cummings, MD; Haltiwanger, RC; Trescher, G; Wang, B; Hemling, ME; Quinn, CJ; Cheng, HY; Lin, F; Smith, WW; Janson, CA; Zhao, BG; McQueney, MS; D'Alessio, K; Lee, CP; Marzulli, A; Dodds, RA; Blake, S; Hwang, SM; James, IE; Gress, CJ; Bradley, BR; Lark, MW; Gowen, M; Veber, DF
err分享
err收藏
Cyclic ketone inhibitors of the cysteine protease cathepsin K
err2001-01-24
err64
PREAI
errMarquis, RW; Ru, Y; Zeng, J; Trout, REL; LoCastro, SM; Gribble, AD; Witherington, J; Fenwick, AE; Garnier, B; Tomaszek, T; Tew, D; Hemling, ME; Quinn, CJ; Smith, WW; Zhao, BG; McQueney, MS; Janson, CA; D'Alessio, K; Veber, DF
err分享
err收藏